Chevron, Johnson & Johnson fall; Novavax, Skyworks rise

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Friday:

Novavax Inc., up $86.93 to $220.94.

The biotechnology company released encouraging results for a potential COVID-19 vaccine.

Robert Half International Inc., up $2.70 to $67.50.

The staffing firm's fourth-quarter profits and revenue beat Wall Street forecasts.

Skyworks Solutions Inc., up $9.46 to $169.25.

The chipmaker blew away Wall Street's fiscal first-quarter profit and revenue forecasts.

Western Digital Corp., up $3.78 to $56.43.

The maker of hard drives reported strong data storage demand and beat analysts' fiscal second-quarter profit forecasts.

Eli Lilly and Co., down $2.15 to $207.97.

The pharmaceutical company's fourth-quarter profit surged with help from sales of its antibody treatment for COVID-19.

Johnson & Johnson, down $6.03 to $163.13.

The pharmaceutical company's potential single-shot COVID-19 vaccine doesn't appear as strong as some of its two-shot rivals.

Chevron Corp., down $3.82 to $85.20.

The oil company's fourth-quarter loss was bigger than analysts' had forecast.

Booz Allen Hamilton Holding Corp., down $10.23 to $85.17.

The defense contractor reported disappointing fiscal third-quarter revenue and lowered its own revenue growth expectations.

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Skyworks Solutions right now?

Before you consider Skyworks Solutions, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Skyworks Solutions wasn't on the list.

While Skyworks Solutions currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Johnson & Johnson (JNJ)
4.9042 of 5 stars
$147.12-1.6%3.24%9.17Hold$175.86
Novavax (NVAX)
3.8309 of 5 stars
$4.16-0.7%N/A-0.75Buy$17.00
Chevron (CVX)
4.9034 of 5 stars
$162.74-0.1%4.01%14.33Moderate Buy$184.75
Eli Lilly and Company (LLY)
4.8464 of 5 stars
$733.85-1.6%0.71%126.53Moderate Buy$728.05
Robert Half (RHI)
4.1751 of 5 stars
$71.40-0.2%2.97%18.45Reduce$68.57
Booz Allen Hamilton (BAH)
4.5938 of 5 stars
$144.04-1.3%1.42%46.46Moderate Buy$145.11
Skyworks Solutions (SWKS)
4.8687 of 5 stars
$101.25+2.0%2.69%17.95Hold$115.10
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

JNJ shares hit a low, trading near $145 at under 14X earnings. With a high dividend yield, it's poised for a rebound.

Search Headlines: